Close

UPDATE: Brean Capital Assumes Nektar Therapeutics (NKTR) at Buy

Go back to UPDATE: Brean Capital Assumes Nektar Therapeutics (NKTR) at Buy
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 1.32 -0.06 (4.35%)
Previous Close $1.38    52 Week High $19.98 
Open $1.36    52 Week Low $10.52 
Day High $1.37    P/E N/A 
Day Low $1.29    EPS $-1.45 
Volume 1,054,027